Cargando…
Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer
AIM: To develop a leptin peptide receptor antagonist linked to nanoparticles and determine its effect on viability of breast cancer cells. METHODS: The leptin antagonist, LPrA2, was coupled via EDAC [1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide] to iron oxide nanoparticles (IONP-LPrA2) to increase...
Autores principales: | Harmon, Tia, Harbuzariu, Adriana, Lanier, Viola, Lipsey, Crystal C, Kirlin, Ward, Yang, Lily, Gonzalez-Perez, Ruben R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309714/ https://www.ncbi.nlm.nih.gov/pubmed/28246585 http://dx.doi.org/10.5306/wjco.v8.i1.54 |
Ejemplares similares
-
Leptin-induced Notch and IL-1 signaling crosstalk in endometrial adenocarcinoma is associated with invasiveness and chemoresistance
por: Daley-Brown, Danielle, et al.
Publicado: (2019) -
Leptin-Notch signaling axis is involved in pancreatic cancer progression
por: Harbuzariu, Adriana, et al.
Publicado: (2016) -
Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer
por: Lipsey, Crystal C., et al.
Publicado: (2020) -
Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer
por: Harbuzariu, Adriana, et al.
Publicado: (2018) -
Leptin signaling and cancer chemoresistance: Perspectives
por: Candelaria, Pierre V, et al.
Publicado: (2017)